AI Science Tracker
EN

Pilot deployment of a machine-learning enhanced prediction of need for hemorrhage resuscitation after trauma - the ShockMatrix pilot study.

Affiliation not stated in the reviewed material · 28 Oct 2024 · medicine

Discovery

Pilot deployment of a machine-learning enhanced prediction of need for hemorrhage resuscitation after trauma - the ShockMatrix pilot study.

Source check: Source checked. Not independent scientific confirmation.

Finding: Traumabase development cohort 28,614, NHR 11%; XGBoost F4 .76 [0.73,.78]; prospective app phase measured feasibility and compared clinician/model likelihood ratios, but article says it was not intended to assess model performance because underpowered. Methods/Results: Traumabase development cohort 28,614, NHR 11%; XGBoost F4 .76 [0.73,.78]; prospective app phase measured feasibility and compared clinician/model likelihood ratios, but article says it was not intended to assess model performance because underpowered. Testing: Methods/Results: Traumabase development cohort 28,614, NHR 11%; XGBoost F4 .76 [0.73,.78]; prospective app phase measured feasibility and compared clinician/model likelihood ratios, but article says it was not intended to assess model performance because underpowered.. XGBoost on nine prehospital predictors produced a defined NHR model and a real-time multicenter feasibility pilot; the pilot was explicitly underpowered to assess model performance. Source affiliation was not stated in the reviewed case checks and was unavailable in the local bibliographic cache.

Technology: Traumabase development cohort 28,614, NHR 11%; XGBoost F4 .76 [0.73,.78]; prospective app phase measured feasibility and compared clinician/model likelihood ratios, but article says it was not intended to assess model performance because underpowered.

Publication: Peer-reviewed paper · Test context: prospective or independent check. Catalog categories, not an evidence grade.

AI contribution
Traumabase development cohort 28,614, NHR 11%; XGBoost F4 .76 [0.73,.78]; prospective app phase measured feasibility and compared clinician/model likelihood ratios, but article says it was not intended to assess model performance because underpowered.
Test and result
Traumabase development cohort 28,614, NHR 11%; XGBoost F4 .76 [0.73,.78]; prospective app phase measured feasibility and compared clinician/model likelihood ratios, but article says it was not intended to assess model performance because underpowered.
Limitation / still unknown
Generalizability beyond the reported study population, data, and protocol was not established in the reviewed material.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://link.springer.com/article/10.1186/s12911-024-02723-9

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 4/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.